These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1707429)

  • 1. Generation of anti-peptide and anti-protein sera. Effect of peptide presentation on immunogenicity.
    McLean GW; Owsianka AM; Subak-Sharpe JH; Marsden HS
    J Immunol Methods; 1991 Mar; 137(2):149-57. PubMed ID: 1707429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid attachment of a helper T cell epitope to branched peptides by fragment condensation to give enhanced immunogenicity.
    McLean GW; Cross AM; Munns MS; Marsden HS
    J Immunol Methods; 1992 Oct; 155(1):113-20. PubMed ID: 1383344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The synthetic peptide 62-75 VP3 of the hepatitis A virus induces virus-binding antibodies].
    Kusov IuIu; Kazachkov IuA; Dzagurov GK; Nastashenko TA; Kozhich AT; Gabrielian AE; Chikin LD; Ivanov VT; Balaian MS
    Vopr Virusol; 1991; 36(2):114-7. PubMed ID: 1652865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological properties of multiple repeats of a linear epitope of herpes simplex virus type 1 glycoprotein D.
    Van der Ploeg JR; Drijfhout JW; Feijlbrief M; Bloemhoff W; Welling GW; Welling-Wester S
    J Immunol Methods; 1989 Nov; 124(2):211-7. PubMed ID: 2480978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model multiple antigenic and homopolymeric peptides from non-repetitive sequences of malaria merozoite proteins elicit biologically irrelevant antibodies.
    Ramasamy R; Kanagaratnam R; Chandanie PD; Kulachelvy K; Ramasamy MS; Dharmasena PM
    Biochim Biophys Acta; 1999 Jan; 1453(1):115-25. PubMed ID: 9989251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologically defined linear epitopes in the E2 envelope glycoprotein of Semliki Forest virus.
    Ariel N; Lehrer S; Elhanaty E; Sabo T; Brodt P; Lachmi B; Katz D; Levin R; Grosfeld H; Velan B
    Arch Virol; 1990; 113(1-2):99-106. PubMed ID: 1696808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of antibody and T cell responses in rabbits immunized with synthetic human B cell epitope analogues of La (SSB) autoantigen.
    Yiannaki E; Vlachoyiannopoulos PG; Manoussakis MN; Sakarellos C; Sakarellos-Daitsiotis M; Moutsopoulos HM; Tzioufas AG
    Clin Exp Immunol; 2000 Sep; 121(3):551-6. PubMed ID: 10971524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody against branched epitope as an affinity ligand to separate the parent protein.
    Yao ZJ; Kao MC; Loh KC; Chung MC
    J Chromatogr A; 1994 Sep; 679(1):190-4. PubMed ID: 7524946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of antipeptide kallikrein 4 antibodies. Use of computer modeling to design peptides specific to Kallikrein 4.
    Harvey TJ; Dong Y; Bui L; Jarrott R; Walsh T; Clements JA
    Methods Mol Med; 2003; 81():241-54. PubMed ID: 12725124
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of multiple-pin peptide synthesis in an analysis of the continuous epitopes recognised by various anti-(recombinant bovine growth hormone) sera. Comparison with predicted regions of immunogenicity and location within the three-dimensional structure of the molecule.
    Beattie J; Fawcett HA; Flint DJ
    Eur J Biochem; 1992 Nov; 210(1):59-66. PubMed ID: 1280219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunization method for generation of high affinity antisera against glucose transporters useful in immunohistochemistry.
    Van Bueren AM; Moholt-Siebert M; Begley DE; McCall AL
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1492-8. PubMed ID: 8280166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and conformational properties of an N-linked glycosylated peptide epitope of human T-lymphotropic virus type 1 (HTLV-I).
    Conrad SF; Byeon IJ; DiGeorge AM; Lairmore MD; Tsai MD; Kaumaya PT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(2):83-92. PubMed ID: 9346859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis and antigenic activity of peptides of the nucleocapsid protein of the hepatitis delta virus].
    Semiletov IuA; Karpova VA; Khudiakov IuE; Pavliuchenkova RP; Viazov SO; Smirnov VD; Prokuronova EI; Zheltukhina GA; Evstigneeva RP
    Bioorg Khim; 1992 Feb; 18(2):252-62. PubMed ID: 1605802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity and potency of proinhibitory antipeptide antibodies against CYP2D6 is enhanced using cyclic peptides as immunogens.
    Schulz-Utermoehl T; Edwards RJ; Boobis AR
    Drug Metab Dispos; 2000 May; 28(5):544-51. PubMed ID: 10772633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
    López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody Production with Synthetic Peptides.
    Lee BS; Huang JS; Jayathilaka LP; Lee J; Gupta S
    Methods Mol Biol; 2016; 1474():25-47. PubMed ID: 27515072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of HLA class I molecules by antisera directed to synthetic peptides corresponding to different regions of the HLA-B7 heavy chain.
    Choppin J; Metzger JJ; Bouillot M; Briand JP; Connan F; Van Regenmortel MH; Levy JP
    J Immunol; 1986 Mar; 136(5):1738-44. PubMed ID: 3081631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and vaccine efficacy of synthetic peptides containing Semliki Forest virus B and T cell epitopes.
    Snijders A; Benaissa-Trouw BJ; Snippe H; Kraaijeveld CA
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2267-72. PubMed ID: 1383405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.
    Nick S; Klaws J; Friebel K; Birr C; Hunsmann G; Bayer H
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():77-83. PubMed ID: 1689371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.